• Professor, Global Health
  • Professor, Medicine - Allergy and Infectious Dis.
  • Adjunct Professor, Epidemiology
Ruanne Barnabas

325 Ninth Ave
Box 359927
Seattle, WA 98104
United States

Phone Number: 
Select from the following:

Ruanne Barnabas is an Associate Professor in Global Health and Medicine at the University of Washington and affiliate at the Fred Hutchinson Cancer Research Center. She is a South African Physician-Epidemiologist. Her research focuses on interventions for HIV and STD treatment and prevention, and, more recently on COVID-19 prevention. She is the protocol chair of the Delivery Optimization for antiretroviral (DO ART) Study, which will evaluate the effectiveness and cost-effectiveness of decentralized, community-based ART initiation compared to clinic- based care. Also, she is the Principle Investigator for the COVID-19 PEP Study. She is the protocol chair for the Kenya Single-dose HPV vaccine Efficacy (KEN SHE) Study, which will evaluate the efficacy of single-dose HPV vaccination for women. She leads the cost-effectiveness evaluation of other projects including scale-up of cervical cancer and HIV treatment and prevention in high burden settings. Her projects use clinical trial data and health economic modeling to estimate the potential impact of interventions. The ultimate aim of her work is to identify effective and efficient treatment and prevention public health strategies.

  • DPhil (University of Oxford)
  • MSc (University of Oxford)
  • MBChB (University of Cape Town (South Africa))
Country Affiliations 
  • Afrikaans
Health Topics 
  • COVID-19
  • Delivery Logistics
  • Health Economics
  • HIV Transmission
  • HPV
  • Infectious Diseases
  • Prevention

Barnabas RV, van Rooyen H, Tumwesigye E, Brantley J, Baeten JM, van Heerden A, Turyamureeba B, Joseph P, Krows M, Thomas KK, Schaafsma T, Hughes JP, Celum C. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda. Lancet HIV. 2016;3:e212-20 [original work]. doi: 10.1016/S2352-3018(16)00020-5. PMCID: 4852382.

Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, and Garnett GP. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med. 2006;3:e138 [original work]. PMCID: 1434486.

Barnabas RV, Brown E, Bershteyn A, Miller RS, Wener M, Celum C, Wald A, Chu H, Wesche D, Baeten JM; Hydroxychloroquine COVID-19 PEP Study Team. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): A structured summary of a study protocol for a randomised controlled trial. Trials. In press [letter].

Barnabas RV, van Heerden A, McConnell M, Szpiro A, Krows ML, Schaafsma TT, Ngubane T, Nxele RB, Joseph P, Baeten JM, Celum C, van Rooyen H; Lotto to Link Study Team. Lottery incentives have short-term impact on ART initiation among men: Results from a randomized pilot study. J Intl AIDS Soc. In press [original work].

Bochner A, Baeten J, Secor WE, van Dam G, Szpiro A, Njenga S, Corstjens P, Newsam A, Mugo N, Celum C, Mujugira A, McClelland S, Barnabas R. Associations between schistosomiasis and HIV-1 acquisition risk in four prospective cohorts: a nested case-control analysis. J Int AIDS Soc. In press [original work].